Related Experiment Video

Updated: May 14, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

[Renal cell carcinoma molecular biology. Prognostic and therapeutic usefulness]

Juan Javier Zudaire Bergera1, Aníbal Rincón Mayans, Jorge Rioja Zuazu

  • 1Departamento de Urología, Clínica Universitaria de Navarra, España. jzudaire@unav.es

Archivos Espanoles De Urologia
|February 15, 2013
PubMed

Insights

Renal cell adenocarcinoma is a therapy-resistant tumor with a genetic basis. Anomalies in the Von Hippel Lindau gene are key to understanding its development and identifying new therapeutic targets.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Context:

  • Renal cell adenocarcinoma presents unique therapeutic challenges due to its resistance to conventional treatments.
  • The genetic underpinnings of renal cell adenocarcinoma are crucial for understanding its complex biology.
  • The Von Hippel Lindau (VHL) gene anomaly is implicated in a significant percentage of these tumors.

Purpose:

  • To review the biological anomalies in renal cell adenocarcinoma.
  • To emphasize the role of the Von Hippel Lindau gene in tumor initiation and progression.
  • To explore potential therapeutic targets based on genetic alterations.

Summary:

  • Renal cell adenocarcinoma exhibits significant therapy resistance and a strong genetic component.
  • Mutations in the Von Hippel Lindau gene are prevalent, influencing tumor biology and development.
  • Current targeted therapies show promise but require further refinement for clinical relevance.

Impact:

  • This review highlights the importance of genetic factors in renal cell adenocarcinoma.
  • Understanding VHL gene anomalies can lead to the development of more effective targeted therapies.
  • Advances in understanding tumor biology pave the way for improved treatment strategies.

More Related Videos

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy

Published on: April 29, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...